Peripheral Blood Mononuclear Cells Market to Grow at 9% until 2025
According to TechSci Research report, “Global Peripheral
Blood Mononuclear Cells Market By Product, By Application, By Technique, By
Source, By Region, Competition, Forecast & Opportunities, 2025”, the global
peripheral blood mononuclear cells market is projected to grow at a CAGR of 9% during
2020 - 2025. PBMC are also called Human Mononuclear Cells from Peripheral Blood
(HMNC-PB) and are made up of lymphocytes & monocytes, and in humans, major
composition of PBMC consists of lymphocytes, followed by monocytes and
dendritic cells. PBMC is crucial to carry out the studies related to biology
and pathology and are also quite useful in clinical applications and research. Additionally,
PMBCs help to find characteristics which are important for research areas such
as immunology, transplant immunology, vaccine development, hematological
malignancies, and others. However, developing nations tend to lack research
practices due to less research institutes, which can eventually lead to less
usage of PBMCs, thereby restraining the market growth.
The global peripheral
blood mononuclear cells market is segmented into product, application,
technique, source, and region. Based on product, the market is segmented into cryopreserved
or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell
isolation & viability kits. Cryopreserved PBMC segment is expected to
dominate the market during the forecast period as frozen PBMC find wide application
in clinical trials. Moreover, PBMCs can be used for long durations of time if
they are stored in a proper way and at lower temperatures. They can even
substitute fresh PBMCs in few applications and thus, making it feasible for the
scientists and researchers to carry out various tests in one laboratory
avoiding inter-laboratory issues.
Based on regional analysis, as of 2019, North
America held the largest market share in the global peripheral blood mononuclear
cells market and the region is anticipated to hold its position during the
forecast period. This is majorly due to the presence of pre-existing PBMC based
research organizations and lab service providers in the region. Some of the major players in the global peripheral blood
mononuclear cells market include Astarte Biologics, Inc., ATZLabs, BioIVT,
BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative
Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck,
Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo
Fisher Scientific and ZenBio Inc., among others. In order to increase their
market share, a rising number of companies are adopting various strategies including
collaborations to attract more customers. For instance, Miltenyi Biotec, an European
PBMC based company, launched a new MACSprep PBMC Isolation Kit in June 14,
2017. The kit is used for processing and diagnosis of small blood samples as it
prepares extremely pure PBMCs via the blood in a very short span of time
without using the procedure of centrifugation.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4561
Customers
can also request for 10% free customization on this report.
“Global
peripheral blood mononuclear cells market is anticipated to witness a steady growth
over the course of next five years. Increase in number of diseases and rise in
number of PBMC based research organizations are some of the major factors
driving the market across the globe. Additionally, increasing incidents of
autoimmune and metabolic diseases are positively influencing the growth of the
market as PBMC is used in studies related to such diseases.,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global management
consulting firm.
“Global
Peripheral Blood Mononuclear Cells Market By Product, By Application, By
Technique, By Source, By Region, Competition, Forecast & Opportunities,
2025” has evaluated the future growth potential of global peripheral
blood mononuclear cells market and provided statistics & information on
market size, shares, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges and opportunities in the
global peripheral blood mononuclear cells market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]